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Brain growth across childhood is a dynamic process associated with specific energy
requirements. A disproportionately higher rate of glucose utilization (CMRglucose)
compared with oxygen consumption (CMRO2) was documented in children’s brain
and suggestive of non-oxidative metabolism of glucose. Several candidate metabolic
pathways may explain the CMRglucose-CMRO2 mismatch, and lactate production is
considered a major contender. The ∼33% excess CMRglucose equals 0.18 µmol
glucose/g/min and predicts lactate release of 0.36 µmol/g/min. To validate such
scenario, we measured the brain lactate concentration ([Lac]) in 65 children to determine
if indeed lactate accumulates and is high enough to (1) account for the glucose consumed
in excess of oxygen and (2) support a high rate of lactate efflux from the young brain.
Across childhood, brain [Lac] was lower than predicted, and below the range for adult
brain. In addition, we re-calculated the CMRglucose-CMRO2 mismatch itself by using
updated lumped constant values. The calculated cerebral metabolic rate of lactate
indicated a net influx of 0.04 µmol/g/min, or in terms of CMRglucose, of 0.02 µmol
glucose/g/min. Accumulation of [Lac] and calculated efflux of lactate from brain are not
consistent with the increase in non-oxidative metabolism of glucose. In addition, the value
for the lumped constant for [18F]fluorodeoxyglucose has a high impact on calculated
CMRglucose and use of updated values alters or eliminates the CMRglucose-CMRO2
mismatch in developing brain. We conclude that the presently-accepted notion of
non-oxidative metabolism of glucose during childhood must be revisited and deserves
further investigations.
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INTRODUCTION
Understanding the metabolic needs of the developing brain
is essential for maintaining brain health across childhood and
during adolescence. Information on the bioenergetic state of
normal children’s brain during development remains limited
due to ethical concerns and overall complexity of conducting
quantitative cerebral metabolic studies using positron emission
tomography (PET) or magnetic resonance spectroscopy (MRS).
Filling this gap in knowledge may shed light on several clinical
predicaments and disease states including understanding the
high incidence of benign febrile seizures in children 18 month
of age (Pavlidou et al., 2013), the increased risk of long-
term cognitive sequelae from multiple anesthesia and surgeries
exposures before age 4 years (Glatz et al., 2017), and the higher
rate of brain overgrowth observed in children with autism
spectrum disorder (Hazlett et al., 2005; Sacco et al., 2015).
In humans, brain growth is rapid after birth and the young
brain reaches adult-sized volume around age six (Giedd et al.,
1999; Lenroot and Giedd, 2006; Semple et al., 2013). Neuronal
maturational processes and myelination rates are dynamic and
varying across the cortex (Bauernfeind and Babbitt, 2014).
Synaptic density peaks at 2–3 years of age followed by pruning
and decreased number (Huttenlocher, 1990; Semple et al., 2013).
Myelination rate remains high until age 10 years (Miller et al.,
2012). The growth pattern of brain development is paralleled by
age-varying energy requirements.
The brain relies predominantly on glucose for energy,
and PET is used to measure rates of glucose consumption
(CMRglucose) with the glucose analog [
18F]fluorodeoxyglucose
(FDG) and oxygen consumption (CMRO2) with
15O-O2 (Raichle
et al., 1976; Mintun et al., 1984; Reivich et al., 1985; Ohta
et al., 1992; Gjedde and Marrett, 2001), allowing for calculation
of the oxygen-glucose index (OGI = CMRO2/CMRglucose). The
theoretical maximum for OGI is 6.0 (6O2 + 1 glucose →
6CO2 + 6H2O) when no other substrates are utilized, and the
OGI therefore falls below 6 when glucose is consumed but not
oxidized. The disproportionate utilization of glucose compared
with oxygen in the presence of normal oxygen delivery is a
phenomenon often called “aerobic glycolysis” in the literature
(Hertz et al., 1998; Vaishnavi et al., 2010; Goyal et al., 2014;
Dienel and Cruz, 2016; Hyder et al., 2016). However, to avoid
confusion, since glycolysis can be upregulated under either
aerobic or hypoxic/anaerobic conditions, we refer here to non-
oxidative metabolism of glucose as glycolytic production of
lactate that is not oxidized and/or of utilization of glucose
by any other pathways that do not consume oxygen via the
mitochondrial electron transport chain (e.g., glycogen synthesis,
pentose phosphate shunt activity, biosynthetic reactions, etc.).
Chugani et al. reported that cortical CMRglucose in newborns
was ∼20–35% lower than in adults, and increased rapidly over
the first 1–3 years (Chugani et al., 1987). In 3–8 year old children,
CMRglucose was twice adult values, followed by a gradual decrease
from 4 to 15 years to attain lower adult levels (Chugani et al.,
1987). These values have become widely accepted and form
the basis of proposals regarding metabolic adaptations in the
developing human brain. Goyal et al. (2014) recently extended
these findings by performing a meta-analysis based on the data
from Chugani et al. and other studies to map trajectories of
CMRglucose and CMRO2, across the human lifespan and reported
a 33% peak of excess CMRglucose over CMRO2 at 3–5 years of
age (Goyal et al., 2014) and an OGI of ∼4.1, inferring enhanced
non-oxidative metabolism of glucose during early childhood
(Goyal et al., 2014). By analogy to cancer cell growth—where
an elevated non-oxidative metabolism of glucose is thought to
support accelerated uptake and incorporation of nutrients into
the growing cancer biomass (Vander Heiden et al., 2009)—it
has been proposed that an elevated non-oxidative metabolism of
glucose in the developing brain would support growth, axonal
elongation synaptogenesis, and remodeling (Bauernfeind et al.,
2014; Goyal et al., 2014).
However, conversion of all of the glucose consumed in excess
of oxygen into brain biomass would cause an impossibly large
increase in brain size, doubling within a month. It is necessary,
therefore, to search for potential explanations for the large
magnitudes of non-oxidative metabolism of glucose reported by
Goyal et al. (2014), which is several-fold higher than in the adult
brain (Hyder et al., 2016). Although a lower than normal OGI
in children’s brain is suggestive of increased glycolytic flux or
non-oxidative metabolism of glucose, the downstream fate of
the glucose carbon has not been established. In other words, the
“OGI” by itself provides no information about the fate of excess
glucose utilization which can involve many pathways as shown in
Figure 1.
A possibility is that a higher-than-normal lactate production
may explain the elevated non-oxidative metabolism of glucose
reported in the developing brain (Goyal et al., 2014). To assess
this concept, we measured steady state lactate concentrations
([Lac]) from brains of 87 children who underwent routine MRI
examination under anesthesia (Jacob et al., 2012) using proton
magnetic resonance spectroscopy (1H MRS), and found that
lactate accumulation and eﬄux could not explain the excess non-
oxidative utilization of glucose. We, therefore, also evaluated
several other possibilities including the storage of the excess
glucose uptake into glycogen, and its complete oxidation or
shunting away from lactate via the pentose phosphate pathway.
At present there is no strong evidence for these possibilities
although they will need to be directly measured before definite
conclusions can be made. We then examined the alternate
possibilities of age dependence on the conversion of the FDGPET
measurement into a calculated rate of CMRglucose and the impact
of plasma ketones, lactate, and other non-glucose substrates on
the OGI calculation.We found that the “lumped constant,” which
is the constant used for the conversion of FDG phosphorylation
to CMRglucose, of Chugani et al. (1987) was considerably lower
than modern accepted values and tested the impact of updated
values on OGI.
Based on our direct measurements of brain [Lac] and
calculations as well as mass balance considerations, we conclude
that the claims of net lactate eﬄux and/or conversion of
glucose into brain mass explaining the enhanced non-oxidative
metabolism of glucose in children compared to adults are
incorrect. There are several other potential metabolic sources
of the reported glucose uptake/oxidation mismatch, including
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FIGURE 1 | Metabolic pathways of importance for the developing brain. Glycolysis, oxidative phosphorylation via the citric acid (TCA) cycle and the pentose
phosphate pathway generating NADPH, and the use of ketone bodies as supplemental fuel are shown. The connections between glycolysis, complex carbohydrate,
amino acid, protein, lipid, and nucleotide synthesis are also illustrated. The pathway fluxes that change during brain development to cause glucose utilization in excess
of oxygen (enhanced non-oxidative metabolism of glucose) are not known. Glucose can be converted to lactate directly via the glycolytic pathway or after shunting
through glycogen or the pentose shunt pathway, then either oxidized in the mitochondria or released from brain. Our diagram shows two pathways for mitochondrial
lactate oxidation, direct lactate transport into the mitochondria and oxidation as has been reported in studies of muscle and brain (Brooks, 1986, 2000, 2018; Schurr,
2006; Passarella et al., 2014; Rogatzki et al., 2015) and conversion of lactate to pyruvate in the cytosol by cytosolic lactate dehydrogenase (cLDH) and subsequent
transport into inner matrix of the mitochondria through pyruvate transporters. Although in muscle it has been reported that the large majority of lactate is directly
oxidized in the mitochondria by mitochondrial LDH (mLDH), the effective blocking of glucose oxidation in brain cell cultures, synaptosomes, and brain slices by
inhibition of the malate aspartate shuttle (MAS) (which transports the redox equivalent from NADH produced by cLDH into the mitochondria) (Fitzpatrick et al., 1983;
Kauppinen et al., 1987; Cheeseman and Clark, 1988; Mckenna et al., 1993) and the inability of L-lactate to rescue glutamate toxicity in MAS-knockout neurons
whereas it does in wild type (Llorente-Folch et al., 2016) suggests that brain mitochondria mainly use cytosolic pyruvate as an oxidative source. Also, LDH is
considered to be a cytoplasmic marker in subcellular fractionation studies of brain (Johnson and Whittaker, 1963; Tamir et al., 1972), and <1% of the LDH in a brain
homogenate is recovered in purified mitochondria (Lai and Clark, 1976; Lai et al., 1977). However, from the standpoint of this study the two pathways of lactate
oxidation would lead to the same OGI as shown in Figure 2. Glucose can also be used for synthesis of glycogen, amino acids, proteins, complex carbohydrates,
lipids, glycolipids, and glycoproteins, and nucleotides. The flux of the pentose shunt in developing brain is higher than in adult brain even though maximal capacity is
similar at all ages (Baquer et al., 1977). The illustration is based metabolic pathways active in proliferative cells to explain the Warburg effect that involves aerobic
glycolysis and lactate efflux (Vander Heiden et al., 2009). Warburg theories for cancer cells state that the increased glucose uptake is shunted through the pentose
phosphate pathway for the additional NADPH needed for biosynthetic reactions. Theoretically, 5/6 of the glucose entering the oxidative branch of the pentose
phosphate pathway should end up as lactate and be exported from the brain. However, if recycling of Fru-6-P back into the pentose shunt is complete, this pathway
can contribute a higher fraction to the consumption of glucose in excess of oxygen (see text). It is an open question how much NADPH is needed to meet the
biosynthetic needs for synaptogenesis. CoA, Coenzyme A; P, phosphate; FBP, fructose-1,6-P2; PEP, phosphoenolpyruvate. Modified from Figure 3 of Vander Heiden
et al. (2009) with permission of the authors. Reprinted with permission from AAAS.
alternate pathways of glucose metabolism or even other
substrates. For example, ketone metabolism is known to be
higher in children, but this would reduce the measured rate
of non-oxidative metabolism of glucose by increasing the OGI.
However, there are limited measurements available on these
alternate pathways. We show through simulations that a more
likely explanation, at present, is the use of different lump
constants in PET CMRglucose data in children and adults.
When modern LC values are used with the originally reported
Chugani et al. results (Chugani et al., 1987), the difference
in non-oxidative metabolism of glucose between adults and
children disappears. However, until the necessary studies are
performed, our present understanding of glucose metabolism in
the developing brain, despite being widely accepted, is at best
incomplete and potentially largely incorrect and deserves further
investigation. The non-oxidative metabolism of glucose “story”
is more complex than conversion of glucose into brain mass or
lactate.
MATERIALS AND METHODS
De-identified 1HMRS spectra and anatomical T1-weighted scans
from 87 children (age: 2–7 years, 38 females and 49 males)
undergoing diagnostic MRI under anesthesia were included
in the analysis. 1H MRS metabolite data from 60 of the 87
children included were previously reported in a study not focused
on lactate but documenting cerebral metabolomic profiles
during different anesthesia regimens; and study procedures are
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described in detail in Jacob et al. (2012). Briefly, after IRB
approval [Committees on Research Involving Human Subjects
(CORIHS), Stony Brook University] and parental consent,
children (2–7 years) were anesthetized with sevoflurane (N =
37) or propofol (N = 50) and underwent routine MRI imaging
for clinical evaluation. Common clinical indications for the
diagnostic MRI scans included seizures, headache, and potential
developmental delay (Jacob et al., 2012). Exclusion criteria were
acute brain trauma, stroke or hemorrhage or any confirmed
diagnosis of elevated intracranial pressure (Jacob et al., 2012).
Scanning was performed on a 3.0T Philips Achieva whole body
scanner, and high resolution T1-weighted and single voxel 1H
MRS were performed in each session. A T1-weighted turbo
field echo sequence was acquired in the sagittal plane at voxel
dimensions of 0.94× 0.94× 1.00mm.
Data Analysis
For gray matter and white matter analysis, the T1-weighted scans
were segmented using SPM8 (Ashburner and Friston, 2000).
The 1H MRS single-voxel point-resolved sequence (PRESS)
was acquired in the cortex (e.g., parietal or temporal lobes)
with following parameters voxel size of 1.5 × 1.5 ×1.5 cm3,
TR/TE/2000 ms/32ms, receiver bandwidth = 1200/2000Hz,
number of points = 1024/2048, and averages = 256. In
the current analysis, the following metabolite concentrations
were quantified and extracted from the spectra by linear
combination of model (LCModel) analysis using the water
concentration as an internal reference (Provencher, 2001): N-
acetylaspartate (NAA) + N-acetylaspartylglutamate (NAAG) =
tNAA; phosphorylcholine + glycerophosphorylcholine = total
choline (tCh); creatine+ phosphocreatine= total creatine (tCr);
glutamate + glutamine = tGlx, and lactate (Lac). Partial volume
effect in the water concentration was also considered in the
concentration calculation (Lee et al., 2013).
Calculation of the Cerebral Metabolic Rate
of Lactate
To assess the degree of CMRglucose-CMRO2 uncoupling
consistent with the measured lactate levels and to compare with
previous reported CMRglucose and CMRO2 in early childhood, we
calculated the cerebral metabolic rate of lactate, CMRlac, as the
difference between the unidirectional transport of lactate into the
brain (Vin) and the lactate eﬄux (Vout) from the brain, Equation
1 (Boumezbeur et al., 2010), i.e., it is net lactate carbon flux
across the blood-brain barrier. CMRlac is defined as the cerebral
metabolic rate of either net lactate production or consumption of
plasma lactate by the brain. The two parameters Vin and Vout can
be calculated based on Equation 2, 3, and CMRLac, [Lac]p, and
Lac]B can be calculated with Equation 4 when different values
for lactate concentrations or VMAX are used:
CMRLac = Vin − Vout (1a)
CMRLac = −2 (CMRglucose − CMRO2/6) (1b)
Vin = VMAX
[Lac]p
KT + [Lac]p + [Lac]B
(2)
Vout = VMAX
[Lac]B
KT + [Lac]p + [Lac]B
(3)
CMRLac = VMAX([Lac]p − [Lac]B)/(KT + [Lac]p + [Lac]B) (4)
Where [Lac]p and [Lac]B are the concentrations of lactate in
arterial plasma and brain, respectively. Since we did not measure
[Lac]p in the children we set it to be 0, 1, or 2mM for the
calculations, which is a reasonable range for the estimate since
the clinical guides report normal plasma [Lac] in children in
the range of 0.5–2mM (Agrawal et al., 2004) and none of
the children in our study was acutely sick or suffering from
chronic infections (Jacob et al., 2012). Lactate transport kinetic
parameters VMAX and KT determined previously in adult brain
of 0.4 µmol/g/min and 5.1mM, respectively were used for the
calculations (Boumezbeur et al., 2010). We also examined the
impact of a 3, 5, and 10-fold higher VMAX, based on studies of
neonatal rats demonstrating that transport kinetics are elevated
in young rat brain when compared to adult brain (Cremer et al.,
1979).
Calculation of the Effect of Different
Substrates on the Measured OGI
Figure 2 shows the stoichiometries used in order to calculate
the effect of different substrates on the measured OGI. We
also give the equations (Figure 2; Table 4) for the oxygen-
carbohydrate index (OCI) and oxygen carbohydrate ketone index
(OCKI) which take into account the oxidation of lactate and
lactate plus ketones, respectively, as opposed to only glucose
in the OGI. As illustrated in Figure 2, oxygen consumed
by complete oxidation of different substrates varies with the
number of carbon atoms (and oxidation of β-hydroxybutyrate to
acetoacetate before entering the TCA cycle), and it is necessary
to take the stoichiometry into account when calculating molar
oxygen/substrate ratios. When all substrates are included in the
same calculation, the molar equivalent carbon each substrate
is expressed relative to the oxygen consumed by glucose. For
example, lactate and pyruvate would consume 3O2, and are
equivalent to 0.5 glucose. Use of these calculations emphasizes
the stoichiometry of net utilization of substrate(s) compared with
oxygen, and has been used in OCI calculations during exercise
to exhaustion (Quistorff et al., 2008; van Hall et al., 2009). Thus,
if glucose is taken up into brain and converted to pyruvate that
is transported into and oxidized in mitochondria or converted
to lactate in cytoplasm, followed by its uptake and oxidation
in mitochondria, the same number of moles of oxygen will be
consumed per glucose. On the other hand, if lactate is released
from brain or if non-oxidative metabolism predominates, the
oxygen/substrate index falls below the theoretical maximum. In
addition, if brain glycogen is consumed, as during hypoglycemia
(Oz et al., 2009) or brain activation (Swanson et al., 1992;
Cruz and Dienel, 2002), the additional carbon fuel must also
be taken into account. In the present study, the children were
anesthetized and glycogenolysis is not anticipated to be increased,
since glycogen turnover in resting brain is very slow (Watanabe
and Passonneau, 1973). However, glycogenmay have contributed
to brain metabolism during the CMRglucose and CMRO2 assays,
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FIGURE 2 | Oxygen-substrate stoichiometry in brain. Substrates are delivered to brain by blood where they are metabolized by brain cells that consume oxygen.
Glucose (Glc) and the glucose analog fluorodeoxyglucose (FDG) are phosphorylated by hexokinase (HK) to their respective hexose-6-phosphate (P). FDG-6-P is
trapped in the cell where phosphorylated, whereas Glc-6-P is further metabolized via the glycolytic pathway to a 3-carbon product that can be oxidized in
mitochondria as either as pyruvate (Pyr) via pyruvate dehydrogenase (PDH) in all cells and pyruvate carboxylase (PC) in astrocytes, or as lactate (Lac) that may be
taken up into mitochondria and converted to Pyr by mitochondrial lactate dehydrogenase (LDH) (see text and legend to Figure 1). Glc-6-P can also enter the pentose
phosphate shunt pathway (PPP) to generate NADPH for management of oxidative stress or for use in biosynthetic reactions. The PPP also generates ribulose-5-P
that is a precursor for nucleic acid synthesis and intermediates are rearranged to produce fructose-6-P and glyceraldehyde-3-P that can re-enter the glycolytic
pathway and fructose-6-P may recycled into the PPP. In astrocytes, Glc-6-P is also stored as glycogen. Lactate can be released from brain when non-oxidative
metabolism is upregulated more than the oxidative pathways. Lactate and ketone bodies can also be taken up from blood and oxidized, particularly in suckling
mammals during development, as well as during exercise and starvation, respectively, when their blood levels rise. Different substrates consume different amounts of
oxygen when completely oxidized, and the relationship between total oxygen consumption and total utilization of various substrates is illustrated. The oxygen-glucose
index (OGI) is based on the stoichiometry of glucose oxidation, and assumes no other substrates are metabolized. The same OGI will be obtained whether Lac or Pyr
is oxidized, as long as there is no uptake of these substrates from blood. Metabolism of other substrates is taken into account by the oxygen-carbohydrate (OCI) and
oxygen-carbohydrate-ketone body (OCKI) indicies. Note that Lac and Pyr are converted to glucosyl units. Ketone bodies, acetoacetate (AcAc) and β-hydroxybutyrate
(BHB), are metabolized in mitochondria.
especially if the subjects were stimulated or stressed, and it would
cause errors in calculated OGI.
Statistical Analysis
We analyzed associations between brain volumes and age
using Analysis of Covariance (ANCOVA) with adjustment for
gender. To examine the relation between LCModel-derived
metabolite concentrations and age, an Analysis of Covariance
(ANCOVA) with adjustment for anesthesia regimen (Sevoflurane
or Propofol) and gender was employed. Analysis was conducted
using XLSTAT (Version 2011.4.03).
RESULTS
MRS Spectral Quality
In order to assess spectral quality the 1H MRS spectra were
checked for poor signal-to-noise ratio (SNR), spectral line
width via full width at half maximum (FWHM) and baseline
fluctuations estimated from LCModel analysis (Provencher,
2001), and 13 spectra were excluded. The average FWHM and
SNR of the spectral NAA peaks were 0.028 ± 0.006 ppm and
22.3 ± 4.2, respectively indicating excellent spectral resolution
and sensitivity. Figure 3 shows representative 1H MRS spectra
from the cortex of a 3-year-old child (top) and a 7 year old
child (bottom); and the LCModel-determined lactate peak is
also depicted (blue, scaled × 4 for enhancing the peak). The
Cramer–Rao lower bounds (CRLBs) which are the standard error
estimates expressed in percent of the estimated concentrations
(%SD) calculated by LCModel analysis (Provencher, 2001) for
[tCr], [tNAA], [tCh] were 2–5%SD; and CRLB’s for [tGlx] were
8–14%SD. The CRLB’s for [Lac] were considerably higher and
[Lac] <0.1mM were discarded leaving 65 subjects with [Lac]
for analysis, and the average CRLB for these was 80 ± 35%SD.
The high CRLB for [Lac] was due to its low concentration
in the brain being on the order of the noise level in some
subjects.
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FIGURE 3 | 1H MRS spectra from a 3-year-old and a 7-year-old child. Representative proton magnetic resonance spectroscopic (1H MRS) spectra from parietal
cortex of children anesthetized with sevoflurane and analyzed by LCModel. The spectra are of excellent quality with sufficient water suppression and spectral
resolution to resolve at least 6–10 metabolites. The raw unsmoothed spectra are shown (black) in addition to the LCModel-fitted output (red solid lines). NAA,
N-acetylaspartate; Glx, glutamate + glutamine; tCr, total creatine; mI, myo-inositol; tCho, total choline; MM, macromolecules. The LCModel- defined lactate peaks on
the two spectra are shown in blue (scaled x4 for enhancing visualization of the peaks).
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Brain Morphometry and Metabolites
Across Early Childhood (2–7 Years)
Global brain morphometric analysis revealed that total gray
matter (GM) and white matter (WM) in the children significantly
correlated with age in the expected, positive direction (GM R2
= 0.14 WM R2 = 0.36, p < 0.001, Figure 4). For GM, 15% of
the variability was explained by the two variables, with age being
significant (p = 0.003) but not gender (p = 0.082). For WM,
39% of the variability was explained by the two variables, with
age being more influential (p< 0.0001) compared to gender (p<
0.001). The concentration of tNAA ([tNAA], a neuronal marker)
was in the range of 5–6mM and also positively correlated with
the children’s age in agreement with a previous report (Kadota
et al., 2001), but not with gender (Table 1). However, in contrast
to [tNAA], none of the other metabolites including [tCr], [tCho],
[Lac], or [tGlx] appeared to follow a linear age-dependency
pattern (Table 1).
Trajectory of Brain Lactate in Early
Childhood
We characterized the trajectory of the brain concentration of
lactate, [Lac] across the children’s ages, because previous reports
documented enhanced levels of non-oxidative metabolism of
glucose in early childhood and the peak excess CMRglucose over
CMRO2 occurred at 3–5 years of age (Goyal et al., 2014). Figure 5
shows the mean cortical [Lac] for each year of children aged
2–7 years, anesthetized with either sevoflurane or propofol and
demonstrates that in all children, regardless of age and anesthetic,
[Lac] is <1mM. Further, we did not observe a [Lac]B peak
at ∼ at 3–5 years, however, [Lac]B in children anesthetized
with sevoflurane was noted to be highest at ∼5 years of age
and reached a level of 0.28 ± 0.20mM. Thus, mean cortical
[Lac] in children is lower than the reported [Lac] values in
brain of unanesthetized adults (0.5–1.0mM) (Prichard et al.,
1991; Bednarik et al., 2015; Rowland et al., 2016). Second, to
explore the age-dependent relation with the AG trajectory (Goyal
et al., 2014), we performed a Lowess, non-parametric regression
of [Lac] from children anesthetized with sevoflurane which is
shown in Figure 6A.
Calculation of CMRLac and Quantitative
Evaluation of its Contribution to Elevated
Non-oxidative Metabolism of Glucose
Using the standard reversible Michaelis-Menten model for brain
lactate transport (Simpson et al., 2007; Boumezbeur et al., 2010)
we calculated the magnitude and direction of brain lactate
transport. Table 2 presents the calculated CMRLac for brain [Lac]
for 4 year old children anesthetized with sevoflurane [average
brain [Lac] was 0.28 ± 0.20mM (range: 0.12–0.54mM)]. Using
previously measured plasma lactate concentrations in children of
∼1mM (Agrawal et al., 2004) and the kinetic constants for lactate
transport measured previously in adults the calculated value of
CMRLac was for net entry into the brain at a relatively low rate
(0.04 µmol/g/min). The lactate that entered the brain would be
oxidized, raising CMRO2 and causing errors in calculated OGI
that does not account for lactate oxidation, as does the oxygen-
carbohydrate index (OCI, Figure 2, Table 4). A net eﬄux of
lactate only occurred if plasma lactate were assumed to be 0mM
and also would be at a very low rate (−0.02µmol/g/min, Table 2)
and much lower than the lactate eﬄux rate needed to account for
FIGURE 4 | Morphometric brain analysis across childhood. Total brain gray (A) and white (B) matter volumes in male (M, blue circles) and female (F, red circles)
children as a function of age. Linear regression analysis shows significant brain growth in gray matter (GM R2 = 0.147, p < 0.001; WM R2 = 0.385, p < 0.0001). For
GM, 15% of the variability was explained by the two variables, with age being significant (p = 0.003) but not gender (p = 0.082). For WM, 39% of the variability was
explained by the two variables, with age being more influential (p < 0.0001) compared to gender (p < 0.001).
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TABLE 1 | Analysis of energy metabolites by age with gender and anesthesia
regimen as covariates.
[Lac] [tCho] [tNAA] [tCr] [tGlx]
R² 0.021 0.030 0.180 0.061 0.034
F 0.437 0.862 6.066 1.801 0.970
P-value 0.727 0.464 0.001 0.153 0.411
Age F 0.513 0.474 7.459 0.007 2.133
P-value 0.477 0.493 0.008 0.935 0.148
Gender F 0.354 2.311 1.538 0.040 0.657
P-value 0.554 0.132 0.218 0.841 0.420
Anesthesia F 0.122 0.062 10.281 5.355 0.120
P-value 0.728 0.803 0.002 0.023 0.730
ANCOVA (Analysis of COVAriance) was used to analyze interactions between brain
metabolites and age and anesthesia regimen. Given the R2 for [tNAA], 18% of the variability
of the dependent variable—[tNAA]—is explained by the three explanatory variables.
Among the explanatory variables, the anesthesia regimen and age are the most influential.
Bold values are statistically significant.
FIGURE 5 | The concentrations of cerebral cortical lactate in children aged
2–7 years. Concentrations of lactate, [Lac], for each year of children aged 2–7
years, anesthetized with either sevoflurane or propofol are means + SD. For
sevoflurane the ranges of [Lac] are given below: Age 2 years: 0.24–0.35mM;
Age 3 years: 0.13–0.37mM; Age 4 years: 0.12–0.54mM; Age 5 years:
0.15–0.51mM; Age 6 years: 0.16–0.39mM; Age 7 years: 0.11–0.20mM. The
number of subjects in each age group for the two anesthetics are as follows:
Sevoflurane group: Age 2 (N = 5); Age 3 (N = 5); Age 4 (N = 6); Age 5 (N =
5); Age 6 (N = 6); Age 7 (N = 3). Propofol group: Age 2 (N = 5); Age 3 (N =
10); Age 4 (N = 6); Age 5 (N = 7); Age 6 (N = 4); Age 7 (N = 3). Please note
that “Age 2,” children ≥2 yrs, <3 yrs; “Age 3 yrs,” children ≥3 yrs, <4 yrs;
“Age 4 yrs,” children ≥4 yrs, <5 yrs; “Age 5 yrs,” children ≥5 yrs, <6 yrs; “Age
6 yrs,” children ≥6 yrs, <7 yrs; “Age 7 yrs,” children ≥7 yrs, <8 yrs.
the mismatch between glucose uptake and oxygen consumption
derived by Goyal et al. of−0.36 µmol/g/min.
To assess the impact of the kinetic constants used from
adult brain on the calculations we also examined the impact of
increasing the Vmax for lactate transport by a factor of 3, 5, and
10. At typical plasma lactate levels of 1mM the calculated CMRlac
increased but the directionality (into the brain) remained the
same. Based on studies in animal models (Cremer et al., 1979)
themaximum anticipated increase in lactate transport in children
was 3-fold and assuming 0 plasma lactate the eﬄux of lactate
would only be −0.07 µmol/gm/min which again is well-below
the predicted−0.36 µmol/g/min. Note that, based on Equation 4
lactate eﬄux can only occur when [Lac]B exceeds [Lac]p.
In order to assess the concentration of brain lactate which
would be required to account for the reported mismatch we
calculated brain lactate concentration [Lac]B for a CMRlac of
−0.36 µmol/g/min (Table 2). Using the VMAX measured in
adults and varying the plasma lactate concentration from 0 to
2mM yielded a predicted brain [Lac] ranging from 46 to 84mM.
Even with a 5-fold increase in VMAX assumed the brain [Lac]
would have to be between 2.6 and 4.0mM which is 8–12 times
higher than the measured value.
Re-calculating CMRglucose and OGI Across
Childhood Using Updated Values for the
Lumped Constant
Because brain lactate levels and calculated lactate eﬄux rates
based on our data were too low to explain the low OGI reported
in children (Goyal et al., 2014), we considered and evaluated an
alternative explanation for low OGI. The FDG-PET literature has
reported and discussed updated values for the lumped constant
(LC), the factor that accounts for kinetic differences in rates of
transport and phosphorylation between FDG and glucose and is
used to convert [18F]FDG phosphorylation rate to CMRglucose.
Based on our review of the Supplemental Table 1 of Goyal et al.
(2014) the CMRglucose data were taken from Table 1 of Chugani
et al. (1987) in which a LC of 0.42 was used for subjects of all ages
as originally published for adult brain by Phelps and coworkers
(Phelps et al., 1979; Huang et al., 1980). Since that time higher
values for adult brain have been found with recent values close to
0.8–0.85 (Graham et al., 2002; Hyder et al., 2016).
Due to the uncertainty regarding the true value of the LC,
we re-calculated the CMRglucose using LC = 0.65, a value
subsequently determined in the Phelps laboratory for adult brain
(Wu et al., 2003) that also determined LC = 0.42, the value
used by Chugani et al. (1987), as well as LC = 0.80, a value
determined by Hyder et al. (2016) that is within the range of
the higher values noted above. We performed the calculations
based on the peak CMRglucose = 0.58 µmol/g/min and OGI
= 4.1 in the loessR plot in Figure 2A of Goyal et al. (2014).
When LC = 0.80 was used, CMRglucose fell and approached
CMRglucose for normal adults (Table 3). Importantly, the OGI
increased from 4.1 to 6.4 and 7.9 when higher values for the
LC were used, and the magnitude of non-oxidative metabolism
of glucose representing ∼33% CMRglucose in excess of CMRO2
was reversed. When LC was increased by 55% from 0.42 to
0.65, CMRO2 and CMRglucose were nearly stoichiometrically
matched because the calculated CMRglucose was reduced by a
corresponding percentage (Table 3). There was no excess glucose
consumed and the predicted lactate uptake agrees with calculated
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FIGURE 6 | The concentration of cerebral cortical [Lac] and CMRglucose across childhood. (A) Cerebral cortical [Lac] from children anesthetized with sevoflurane is
plotted as a function of age (black circles). A Lowess regression (locally weighted regression and smoothing scatter plot) was fitted to the data using XLSTAT (Version
18.07); and is represented by the red circles. (B) Whole brain CMRglucose data as reported by Goyal et al. (2014) (black triangles) is shown in relation to the Lowess fit
of the [Lac] data (red circles).
CMRLac of +0.04 µmol/g/min based on measured brain [Lac]
(Figures 5, 6; Table 2).
Goyal et al. (2014) strongly emphasized the temporal profile
of enhanced non-oxidative metabolism of glucose (higher
CMRglucose compared with CMRO2) in children 1–10 years of
age, with a peak at about 5 years of age (as illustrated in
Figure 6B). However, due to the uncertainty in the true value
for the LC and its high impact on OGI and therefore on the
magnitude of non-oxidative metabolism of glucose revealed
by calculations as illustrated in Table 3, we recalculated the
CMRglucose trajectories with updated values for the LC along
with CMRO2. Figure 6A shows the age-dependent changes for
the Goyal data for CMRglucose (blue) and CMRO2 (red, expressed
in glucose equivalents as calculated by Goyal et al., CMRO2/6,
a calculation that assumes all oxygen consumed is due to
glucose oxidation), and for re-calculated values with LC = 0.65
(green), and LC = 0.80 (brown). When higher LC values were
used the discrepancy between CMRglucose and CMRO2 was age-
dependent, with CMRO2 exceeding CMRglucose in 1–2 year old
children, and nearly-stoichiometric rates at ages 5–10 years
(Figure 6A).
DISCUSSION
In this study we measured brain [Lac] in 65 children across 2–
7 years and documented that [Lac]B on average was <0.3mM
throughout and below previous MRS measurements in the adult
brain (0.5–0.7mM). In addition, [Lac]B did not peak at 3–5 years
inconsistent with the peak excess CMRglucose over CMRO2 and
low OGI documented at 3–5 years of age (Goyal et al., 2014),
which they ascribed to the needs of increased synaptogenesis.
However, there are other potential reasons for the fall in OGI,
including lactate release from brain. This possibility was ruled
out because the brain [Lac] we measured was many fold below
what is needed to explain the quantitative drop in the OGI
and was consistent with small net brain uptake as opposed
to eﬄux of lactate. We discuss these findings below in light
of what is known about fuel consumption in the developing
brain and evaluate potential metabolic and methodological
explanations for the discrepancy between the reported low OGI
and the brain [Lac] measured. Previous studies have discussed
the quantitative contribution of lactate uptake into resting
adult brain (Boumezbeur et al., 2010), the oxygen/substrate
stoichiometry in brain of non-stimulated, sedentary human
subjects (Hyder et al., 2016), decreases in the ratio during brain
activation (Dienel and Cruz, 2016), and the contributions of
glucose and lactate during exhaustive exercise (Quistorff et al.,
2008; van Hall et al., 2009). The present study examines the
basis for decreases in this ratio in brains of children during
development.
Enhanced Aerobic Non-oxidative
Metabolism of Glucose in the Developing
Brain and Relation to Brain Lactate
To assess whether lactate eﬄux could account for the low OGI
reported in early childhood we calculated CMRLac based upon
the measured concentration of brain lactate and literature values
for plasma lactate concentration and transport kinetics. As shown
in Table 2 these calculations indicate that based on the measured
brain [Lac] an inflow of plasma lactate is predicted. In order
to obtain lactate eﬄux sufficient to account for the reported
elevated non-oxidative metabolism of glucose (and low OGI)
brain [Lac] ranging from 46 to 84mM (with the range based
upon the concentration of plasma lactate and adult brain kinetic
constants) were calculated which is two orders of magnitude
above the measured values.
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TABLE 2 | Calculated values for CMRLac, [Lac]p, and [Lac]B.
Calculated value Fixed values
CMRLac
(µmol/g/min)
[Lac]p
(mM)
[Lac]B
(mM)
VMAX
(µmol/g/min)
KT
(mM)
CMRLac = −0.02 – 0 0.28 0.4 5.1
CMRLac = +0.05 – 1 0.28 0.4 5.1
CMRLac = +0.09 – 2 0.28 0.4 5.1
CMRLac = −0.06 – 0 0.28 1.2 5.1
CMRLac = +0.14 – 1 0.28 1.2 5.1
CMRLac = +0.23 – 1 0.28 2.0 5.1
CMRLac = +0.45 – 1 0.28 4.0 5.1
[Lac]B = 46 −0.36 0 – 0.4 5.1
[Lac]B = 65 −0.36 1 – 0.4 5.1
[Lac]B = 84 −0.36 2 – 0.4 5.1
[Lac]B = 2.6 −0.36 1 – 2 5.1
[Lac]B = 4.0 −0.36 2 – 2 5.1
Values were calculated with Equation 4: CMRLac = VMAX ([Lac]p - [Lac]B )/(KT + [Lac]p
+ [Lac]B ). The present study measured brain lactate concentration ([Lac]B ) = 0.28mM
in 5-year-old sevoflurane anesthetized children (Figure 5), but their plasma lactate
concentrations ([Lac]p ), the kinetic constants for lactate transport across the blood-brain
barrier (VMAX and KT ), and the rate of lactate utilization (CMRLac) are not known. Two
questions were, therefore, posed: (1) What is calculated CMRLac based on measured
brain [Lac] and different values for plasma lactate concentration and VMAX? (2) What is
brain lactate level when CMRLac is fixed and plasma lactate level and VMAX are varied?
Positive or negative values for CMRLac denote net influx or efflux of lactate into or from
brain, respectively. Measured values for VMAX (0.4 µmol/g/min) and KT (5.1mM) in
normal adult human brain are from Boumezbeur et al. (2010) Because VMAX is higher
in developing rodent brain (but not known in human children), values were increased 3,
5, or 10-fold for the calculations. Note: (i) net lactate uptake occurs when plasma lactate
level exceeds that in brain, and lactate efflux occurs when brain lactate level exceeds that
in plasma, and (ii) calculated values for brain lactate levels based on adult kinetic constants
are not realistic.
An alternate possibility to explain our data in relation to
previously-reported data (Goyal et al., 2014) is that children
have several-fold higher lactate transport activity through
the monocarboxylate transporter (MCT) system than adults.
Preclinical data in rodents show that the expression of MCTs is
higher in neonates than in adults (Gerhart et al., 1997). Cremer
et al. measured MCT transport in neonatal and adult rats and
the transport kinetics were found to be ∼3-fold higher in the
neonates (Cremer et al., 1979). Assuming that VMAX is 5-fold
higher we calculated a minimum brain [Lac] needed to account
for elevated non-oxidative metabolism of glucose of 2.6mM
which, is 9-fold greater than the measured values. Using the
measured value of brain [Lac] the impact of a higher VMAX would
be to increase lactate influx (Table 2). We note that a 3-fold
higher value is most likely, well-above the elevation, if any, in the
children studied since it was obtained from rat pups that were not
yet weaned, during which time there is a much higher percentage
of ketones and other monocarboxylic acid substrates consumed
by the brain (Chowdhury et al., 2007).
Overall our 1H MRS data - which were not supportive of
lactate eﬄux from children’s brain - are in agreement with
previous data reporting a cerebral arterio-venous (AV) difference
for lactate of ∼0 in seven anesthetized children (Persson et al.,
1972). In another study which documented AV-differences of
glucose and oxygen in children, OGI was close to the expected
theoretical value of 6:1 (Settergren et al., 1976) (see ketones as
alternate fuels and Table 4, below).
Alternate Metabolic Pathways to Explain
High Non-oxidative Metabolism of Glucose
in Early Childhood, a Complex
Phenomenon
The concept of enhanced “aerobic glycolysis” (Goyal et al., 2014)
(i.e., enhanced non-oxidative metabolism of glucose) is derived
from consumption of more glucose than oxygen in the presence
of abundant oxygen. The inference is that glycolytic flux is
increased but the downstream fate of the glucose carbon is not
established. Flux of glucose into many pathways could contribute
to the CMRO2-CMRglucose mismatch (Figure 1). We assess below
possible contributions from these pathways.
Pentose Phosphate Pathway
One alternate possibility to explain the elevated non-oxidative
metabolism of glucose is the pentose phosphate pathway. The
use of glucose for biosynthesis involves both energy production,
production of NADPH via the pentose phosphate pathway, and
use of different pathways to incorporate glucose carbon into
macromolecules that might be used for synaptic remodeling
(Figure 1). Studies of the pentose phosphate pathway in adults
(Baquer et al., 1988) suggest that it works primarily in the
direction of NADPH production in which 1 carbon is lost per
glucose that goes through the pathway with the remainder of the
carbons reentering glycolysis and being converted to pyruvate
and lactate. Therefore, even if all the glucose phosphorylated into
glucose-6-phosphate (Glc-6-P) enters the pentose shunt it would
only reduce the rate of glycolysis by 1/6 unless there is a very large
ribose synthesis flux.
However, pentose phosphate pathway activity is higher during
brain development (Baquer et al., 1977, 1988), and a greater
fraction of glucose carbons may not enter glycolysis immediately
[either being removed as riboses or lost through extensive cycling
at the level of fructose-6-phosphate (Fru-6-P) which can be
in relatively fast exchange with Glc-6-P via phosphoglucose
isomerase (Rodriguez-Rodriguez et al., 2013); Figure 1] resulting
in a larger underestimate of the CMRO2-CMRglucose mismatch
based on lactate production and levels. In fact, if recycling
is complete, the shunt could explain most or all of the fall
in OGI. The stoichiometry of the pentose shunt is 3 Glc-6-
P → 3 CO2 + 2 Fru-6-P + 1 glyceraldehyde-3-phosphate
(GAP). If all of the Fru-6-P is recycled by conversion to Glc-
6-P that re-enters the shunt pathway, then one “new” Glc-6-P
from glucose (or glycogen) is required per cycle, with the net
result that for each glucose that enters as Glc-6-P, 3 CO2 + 1
GAP are produced. If the GAP is oxidized, the OGI would be
3 because half of the equivalents of the incoming glucose are
converted to CO2 without oxygen consumption. If the GAP is
converted to lactate and released from brain, OGI = 0. High
activity of the pentose shunt in young children coupled with
complete Fru-6-P recycling could explain both the low OGI and
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TABLE 3 | Estimates of changes in OGI and lactate efflux rates from brain of children when updated values for the lumped constant are used to calculate CMRglucose.
Lumped constant CMRglucose (µmol/g/min) OGI CMRO2/6 (µmol/g/min) CMRO2-CMRglucose stoichiometric mismatch
CMRglucose-(CMRO2/6) (µmol/g/min) Equivalent CMRLac (µmol/g/min)
0.42 0.58 4.1 0.4 0.18 −0.36
0.65 0.37 6.4 0.4 −0.03 +0.06
0.80 0.30 7.9 0.4 −0.10 +0.20
Analysis of the stoichiometric mismatch between oxygen and glucose was evaluated using equation 1b: CMRLac = −2[CMRglucose - (CMRO2/6)] for different values for the lumped
constant that alter calculated CMRglucose. CMRLac is assigned a negative value to denote release of glucose equivalents from brain when CMRglucose exceeds CMRO2; positive values
are obtained when CMRO2 exceeds CMRglucose and indicate oxidation of other substrates (carbohydrate or ketone bodies) that were not taken into account in the OGI calculation.
Maximal values of CMRO2 and CMRglucose in the loessR plots for ∼3–5 year old children in Figure 2A of Goyal et al. (2014) i.e., 2.4 and 0.58 µmol/g/min, respectively, were used to
calculate OGI = CMRO2/ CMRglucose. CMRglucose for updated values of the lumped constant was calculated by multiplying CMRglucose = 0.58 by 0.42/0.65 or 0.42/0.80 and used to
calculate updated OGIs. Stoichiometric balance between CMRglucose and CMRO2 was determined by subtracting the glucose equivalents of maximal CMRO2 (i.e., CMRO2/6 = 2.4/6 =
0.4) from CMRglucose. For comparison to values in brain of normal resting awake adults, OGI determined in 8 independent studies by arteriovenous differences, was 5.95 ± 0.27 (mean
± SD) (Quistorff et al., 2008). This value for OGI was determined by a method independent of the value of the lumped constant. Whole-brain CMRglucose in normal resting awake adult
human brain was 0.26 ± 0.07 µmol/g/min when calculated using the lumped constant = 0.80, whole brain CMRO2 was 1.36 ± 0.37 µmol/g/min, and whole-brain OGI was 5.17 +
0.95 (Hyder et al., 2016).
inability to account for the additional glucose carbon consumed
in excess of oxygen because it is released as CO2. A caveat
is that CO2 production without oxygen consumption via the
pentose shunt would increase the respiratory quotient (RQ—see
legend to Table 4 for definitions and discussion below) above
1.0, the value determined in young children that is indicative of
carbohydrate utilization (Table 4). However, oxidation of ketone
bodies has an RQ of 0.7, and the combination of high pentose
shunt activity plus oxidation of blood-borne ketone bodies in
brain of young children may explain the net RQ = 1. Future
studies in children using 13CMRS technology to directly measure
the pentose phosphate pathway and ketone body utilization
could potentially distinguish these possibilities (Rothman et al.,
2011).
Use of Glucose Carbons as Biosynthesis Precursors
In addition to ribose formation from the pentose phosphate
pathway there are many other pathways by which carbons
derived from glucose can be used for net biosynthesis, such as
for lipids and amino acids. In order to assess this possibility, we
calculated the approximate rate of increase in biomass implied
by the non-oxidative metabolism of glucose mismatch using the
following expression based on the “aerobic glycolysis” data of
Goyal et al. (2014) (see Table 3)
Rate of biomass increase = the rate of “aerobic glycolysis”
(µmol glucose/min/g brain)∗brain weight
For the reported excess of glucose consumption over
oxidation at 5 years old of 0.18 µmol/g/min and an average brain
weight of 1300 g this calculation yields ∼1800 g per month of
additional carbon incorporation. This amount is well-over the
total brain weight (which is∼70%water) and clearly not possible.
An alternate possibility, discussed by Goyal et al. (2014),
is that there is a high level of synaptic turnover so that the
carbon incorporated from glucose into nucleotides, lipids and
proteins in the building of new synapses is largely matched by
synapse breakdown and catabolism of the structural components.
However, if this were the case then the released carbon building
blocks would be oxidized at the same rate as new carbons are
incorporated resulting in a normal OGI value.
Ketones and Lactate as Alternate Fuels in Early
Childhood
A limitation of the OGI is that it only takes into account the
relationship between oxygen and glucose. The oxidation of non-
glucose substrates is assumed to be negligible in adult brain,
which may not be the case in children. Accurate values for the
oxygen-fuel index would require measurement of net uptake
into brain of all alternate substrates (e.g., β-hydroxybutyrate,
acetoacetate, lactate) in plasma plus utilization of brain glycogen.
It is well-known that in the developing brain lactate and
ketones serves as fuel and substrates during the suckling period
and beyond and ketones are essential for brain lipid synthesis
(Settergren et al., 1976). For example, children 2–6 years of
age have been reported to have significantly higher overnight
fasting values of β-hydroxybutyrate and acetoacetate than older
children and adults (Persson et al., 1972). Also, in a study
where children were anesthetized (with N2O) the cerebral uptake
of ketones (acetoacetate and β-hydroxybutyrate) accounted for
∼13% of the measured oxygen uptake, assuming complete
oxidation of the ketones (Settergren et al., 1976). In addition
to ketones our calculations suggest that plasma lactate could
be a net oxidative energy source in the developing brain, albeit
at a low level. The effect of net lactate oxidation would be
to increase the measured OGI due to the increase in oxygen
consumption for the same amount of glucose uptake. As shown
in Figure 2 and Table 4 alternate carbohydrate indicies can be
defined that takes glucose, lactate, and ketone body net uptake
into account (excluding brain glycogen consumption that cannot
be measured in young children and is very difficult to measure in
adults).
Table 4 summarizes results from metabolic studies in awake
and N2O-anesthetized children and reveals the impact of
inclusion of inclusion of lactate and ketone body fluxes on
calculated oxygen/substrate ratios. If lactate eﬄux is not taken
into account in study 1, OGI is too low compared with OCI
(oxygen-carbohydrate index; see legend to Table 4 for definitions
and equations for calculation). When lactate and ketone bodies
are included in the calculation of OCKI (oxygen-carbohydrate-
ketone index), the general trend is for OCI to exceed OGI due
Frontiers in Neuroscience | www.frontiersin.org 11 September 2018 | Volume 12 | Article 631
Benveniste et al. Brain Lactate and CMRO2−CMRglucose Mismatch in Childhood
TABLE 4 | Blood flow, metabolic rates, and calculated oxygen/substrate utilization ratios and brain lactate concentration in brain of young children.
Reference 1a 2b 3d 4e 5f 6g 7h 8 i
Age range (years) 0.5–3.3 3–11 Adults 0.58–14 0.08–0.58 10–15 1–15 21–24
55–65
0–1 1–2 3–8 9–15 19–30
Mean age (years) 0.92 6.1 24.5 12
Number of subjects 10 9 12 7 17 7 42–65 10 7 4 12 6 7
Duration of fasting (h) 3 9 10 15 4 4 4 4 4
Physiological status
during assay
Awake,
15% N2O
Awake,
15% N2O
Awake,
15% N2O
70%N2O awake 75→ 50%
N2O
75→ 50%
N2O
awake All groups awake
Anesthesia duration
(min)
20–40
CBF (ml/g/min) 0.903 1.064 0.601 0.68 0.64
Arterial conc. (µmol/ml)
Glucose
Lactate
Pyruvate
Acetoacetate
β-hydroxybutyrate
1.80
0.094
4.18
1.52
0.08
0.60
1.75
5.21
1.25
0.12
0.28
5.27
1.13
0.104
0.273
0.890
4.57
0.61
0.065
0.159
0.347
(A-V) (µmol/ml)
O2
Glucose
Lactate
Pyruvate
Acetoacetate
β-hydroxybutyrate
2.87
0.726
−0.507
−0.0085
1.49
0.29
−0.03
−0.01
0.08
0.09
2.23
0.48
−0.27
0.03
0.04
2.08
0.33
0.012
0.014
2.17
0.36
−0.07
−0.01
0.018
0.049
CMR (µmol/g/min)
O2
Glucose
Lactate
Pyruvate
Acetoacetate
β-Hydroxybutyrate
2.59
0.656
−0.458
−0.008
2.31c 1.86 1.35
0.248
−0.048
−0.008
0.012
0.034
1.72
0.248
−0.028
−0.004
0.004
0.006
0.204 0.274 0.481 0.392 0.243
Respiratory quotient 1.00 0.97 0.94
OGI 3.95 5.14 4.65 6.3 6.03 6.94 11.3j
6.62k
8.4j
4.93k
4.8j
2.81k
5.9j
3.44k
7.7j
6.91k
OCI 6.13 5.52 6.46 6.3 6.78 7.41
OCKI 3.81 4.56 4.04 5.88 7.19
Calculated O2 uptake 2.81 2.35 2.37 2.09 2.21 1.44
%O2 from ketone
oxidation
30.9 12.7 5.3 13.2 3.0
Lac+Pyr release (%
Glc)
−35.5 −6.9 −28.1 0 −11.3 −6.5
Calc.[Lac]B: VMAX =
0.4
VMAX = 2.0
VMAX = 4.0
−64.8
4.4
2.9
2.14
1.31
1.22
1.08
0.70
0.65
Values are means; those not included were not determined/reported by the tabulated studies.
CBF, cerebral blood flow; (A-V), arteriovenous difference that is positive when there is net uptake into brain and negative when there is net efflux; Glc, glucose; Lac, lactate; Pyr, pyruvate;
AcAc, acetoacetate; BHB, β-hydroxybutyrate; KB, ketone bodies (AcAc + BHB); CMR, cerebral metabolic rate; OGI, oxygen-glucose index; OCI, oxygen-carbohydrate index; OCKI,
oxygen-carbohydrate-ketone index.
Metabolic rates and oxygen/substrate ratios:
CMRsubstrate = CBF(A-V)substrate.
OGI = CMRO2/CMRglucose = (A-V)O2/(A-V) glucose and assumes no other substrates are oxidized.
OCI = CMRO2/[CMRglucose + 0.5(CMRlac + CMRpyr )] = (A-V)O2/[(A-V) glucose + 0.5((A-V)lac + (A-V)pyr )], where pyruvate and lactate are expressed in glucose equivalents 1 glucose
= 2 pyruvate or 2 lactate. OCI takes into account lactate + pyruvate uptake or efflux from brain and assumes no other substrates are consumed, which is generally valid for normal,
non-fasted adults during rest or graded exercise to exhaustion.
OCKI = CMRO2/[CMRglucose + 0.5(CMRlac + CMRpyr ) + 4/6CMRAcAc + 4.5/6CMRBHB ] = (A-V)O2/[(A-V) glucose + 0.5((A-V)lac + (A-V)pyr ) + 4/6(A-V)AcAc + 4.5/6(A-V)BHB ], where
utilization of other substrates are expressed in glucose equivalents for oxygen utilization. Oxidative metabolism of one glucose, one AcAc, or one BHB molecule consumes 6, 4, or 4.5
molecules of O2 (Hawkins et al., 1971). The OCKI calculation accounts for the major substrates consumed or released from brain relative to oxygen.
(Continued)
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TABLE 4 | Continued
Ketone body (KB) oxidation as percent of calculated O2 utilization: Calculated O2 uptake = 6*[(A-V)glc+0.5((A-V)lac + (A-V)pyr )] + 4(A-V)AcAc + 4.5(A-V)BHB, assuming complete
oxidation of ketone bodies. Calculated %KB oxidation = 100*(4(A-V)AcAc+4.5(A-V)BHB )/calculated (A-V)O2. For adults, CMR values replaced (A-V) in the equations.
Lactate-pyruvate release/glucose uptake: Lactate + pyruvate release/uptake from brain (negative value if release) is expressed in glucose equivalents as % of glucose uptake =
100*0.5[(A-V)lac + (A-V)pyr ]/(A-V)glc.
Respiratory quotient (RQ): RQ = volume of CO2 produced/volume of O2 consumed = (A-V)CO2/(A-V)O2. An RQ of 1.0, 0.8 or 0.7 indicates that carbohydrates, proteins, or
lipids/ketones, respectively, are metabolized, with intermediate values indicating mixed fuel utilization.
Calculated brain lactate concentrations: [Lac]B was calculated (Calc.) with Equation 4: CMRLac = VMAX ([Lac]p - [Lac]B ) /(KT + [Lac]p + [Lac]B ) using measured [Lac]p and CMRlac
and different values for VMAX . Positive or negative values for CMRLac denote net influx into or net efflux of lactate from brain, respectively. Measured values for VMAX (0.4 µmol/g/min)
and KT (5.1mM) for plasma-brain lactate transport in normal adult human brain are from (Boumezbeur et al., 2010). For calculations VMAX values 5 or 10 times higher were also used
because based on rodent studies the developing brain may have a higher VMAX for blood-brain barrier lactate transport (Cremer et al., 1979).
aMost children cried and required some restraint during the procedure, especially at time of needle punctures. PCO2 did not change significantly during the procedures.
bThe authors stated that great pains were taken to minimize anxiety in the children, including having the dim lighting, minimal stimulation, and providing a movie on the ceiling that was
considered to be unlikely to influence the global CBF or CMRO2. Low anxiety is supported by recording of mean pulse rates and mean arterial blood pressures were in the range of
normal, resting 6-year-old children. Also, one child that had 4 repeated determinations with no significant changes due to familiarity with the procedure. The authors’ subjective opinion
was that the children were less anxious than the adults.
cGlobal CMRO2 had no significant correlation, positive or negative, with age between age 3 to 10 years.
dChildren were pre-medicated with morphine and atropine, anesthesia induced with thiopentane, intubated, ventilated with 70% N2O/30%O2. Data for mild hypercapnia were also
reported but not tabulated.
eData for infants <0.15 years old were also reported but not tabulated. If the infants completely oxidized the ketone bodies they would account for 13% of total oxygen consumption,
with glucose corrected for lactate efflux accounting for 87%.
fChildren were pre-medicated with morphine, anesthesia induced with thiopentane, general anesthesia with pancuronium (prior to intubation) and 75% N2O/25%O2 that was abruptly
reduced to 50% N2O during the CBF assay. More detailed data for infants <1 year old were also reported but not tabulated. In these infants, blood ketone body concentrations were
much higher than in 12-year-old children, and (A-V) differences for AcAc and BHB were greater in the infants in whom net ketone body uptake accounted for 13% of measured oxygen
uptake, assuming complete oxidation. However, less oxygen was consumed compared to calculated oxidation of glucose corrected for lactate + pyruvate release and ketone bodies,
and this discordance could not be explained. Infants released lactate + pyruvate from brain to blood, equivalent to 6% of glucose uptake. Equally-detailed assays were not reported for
the children.
gChildren were pre-medicated with morphine and atropine, anesthesia induced with thiopentane, general anesthesia with pancuronium and 75% N2O/25%O2 that was abruptly reduced
to 50% N2O during the CBF assay. (A-V) Differences were measured in 42 children (age range 1–15 years old), whereas CBF and O2 were measured in more children, including those
at younger ages. Uptake of the ketone bodies was positively correlated with arterial concentration. CBF and the metabolic rates for oxygen, glucose, lactate, pyruvate, acetoacetate,
and β-hydroxybutyrate were not correlated with age. However, the relationship between measured oxygen consumption and the amount needed for complete oxidation of glucose,
acetoacetate, and β-hydroxybutyrate minus release of lactate + pyruvate was poor, as reported in Settergren et al. (1976); the basis for this finding is unknown. The authors reported
considerable variability in CBF, so OGI, OCI, OCKI, and %lactate released were calculated from (A-V) differences. To calculate [Lac]B for different VMAX values it was necessary to use
CMRLac.
hSubjects were calm and relaxed after catheter insertion. Data were obtained for two groups of adults (21–24 and 55–65 years old; n = 5/group) that were not significantly different,
and results were pooled.
iCMRglucose is for cerebral hemispheres in children who had transient neurological events that did not significantly affect neurodevelopment and were considered to be reasonably
representative of normal children. Some children had medication on the day of the study. Children that became drowsy during the assay were tapped on the shoulder but other stimuli
were minimized. Regional values for CMRglucose were also reported but are not tabulated.
jGlobal CMRO2 = 2.31 from Kennedy and Sokoloff (1957) was used to calculate OGI in awake children because no correlation with age (3–11 years old) was reported, whereas OGI in
awake adults was based on CMRO2 = 1.86 determined in adults.
kGlobal CMRO2 = 1.35 from Settergren et al. was used to calculate OGI because no correlation with age was reported in anesthetized children (1–15 years old), whereas CMRO2 =
1.68 for awake adults was used to calculate OGI for adults. Settergren et al. also reported no age-related correlation of CMRglucose, CMRLac, CMRpyr , CMRAcAc, or CMRBHB across
age between 1–15 years old in anesthetized children, contrasting the results of Chugani et al. (1987) in awake subjects. Note that global CMRO2 in 1–15-year-old anesthetized children
the study by Settergren et al. (1980) is lower than that of awake adults the Lying-Tunell et al. (1980) and Kennedy and Sokoloff (1957) studies, whereas awake children age 3–11 years
old had higher global CMRO2 than awake adults.
1. Mehta et al. (1977); 2. Kennedy and Sokoloff (1957); 3. Settergren et al. (1973); 4. Kraus et al. (1974); 5. Settergren et al. (1976); 6. Settergren et al. (1980); 7. Lying-Tunell et al.
(1980); 8. Chugani et al. (1987).
to correction of glucose uptake for lactate eﬄux in all studies
where measured, then OCKI is falls below OCI due to inclusion
of ketone body uptake (Table 4). In most cases, the calculated
oxygen uptake is similar to the measured oxygen uptake value,
and oxidation of ketone bodies accounted for 3–13% of total
oxygen consumption except for study 3 where calculated oxygen
uptake was 59% higher than the measured value and ketones
accounted for 30% of oxygen uptake. Lactate eﬄux accounted
for 0–11% of glucose uptake in the 0.6–15-year-old N2O-
anesthetized children and 28–36% in children <3.3 years old
when awake, suggesting stress-induced glycolysis/glycogenolysis
and enhanced release. Of interest, OCI in study 1 is 6.1 and the
respiratory quotient (RQ=(A-V)CO2/(A-V)O2) is 1.00 indicating
strictly carbohydrate oxidation, whereas the RQ in older children
was slightly<1, suggesting some ketone body use. (See discussion
above regarding the potential balancing of pentose shunt and
ketone body oxidation to influence the RQ).
Glycogen and the Glycogen Shunt
Little is known about the role of glycogen in energy metabolism
during brain development (Rust, 1994). However, glycogen
turnover with lactate release from brain in conjunction with
synaptic activity would consume glucose without oxygen.
Previous studies have considered the role of the glycogen shunt
(i.e., the cycling of glucose-6-phosphate from the glycolytic
pathway into glycogen and its return upon glycogenolysis) to
explain, in part, the CMRglucose-CMRO2 mismatch observed
during brain activation studies (Shulman et al., 2001). However,
in this case the enhanced glucose uptake relative to oxidation
would result in increased lactate production which would have
been seen in the present study.
Alternatively, net glycogen synthesis could be occurring in
which case there would be an equivalent increase in glucose
uptake resulting in a lower OGI without an increase in lactate
production. In the early preparative aspects of the PET studies of
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awake children, glycogen could have been depleted prior to the
CMRglucose measurement due to stress, sensory stimulation, or
alerting, then re-synthesized during the assay interval. Evidence
exists from animal models supporting enhanced glycogen
breakdown under conditions of stress and increased arousal
(Dienel and Cruz, 2016). In the present study, however, the
children were anesthetized and glycogenolysis is not likely to
contribute to lactate production above the low basal level.
Metabolic Studies in Children Underscore
the Difficulty and Complexity of Accurate,
Fully-Quantitative Determinations of
Non-oxidative Metabolism of Glucose With
Developmental Age
Due to the invasive nature of methods for measuring brain
glucose and oxygen consumption as well as concerns regarding
radiation the number of brain metabolic studies in children is
highly limited. The reports by Kennedy and Sokoloff (1957)
and Mehta et al. (1977) (Table 4) were the only ones (to our
knowledge) to measure CMRO2 in awake children. Kennedy and
Sokoloff stated that there was no correlation of CMRO2 with
age between 3 and 11 years, and dividing the Chugani values
for CMRglucose into the mean CMRO2 gives results (Table 4)
similar to the OGI profile shown for LC = 0.65 in Figure 7B.
In sharp contrast, use of the lower value for CMRO2 from N2O-
anesthesized children resulted in much lower OGI values due to
low CMRO2 in the anesthetized children (Table 4). In both cases,
the OGIs do not reflect the true oxygen/substrate ratio because
the contributions of lactate eﬄux and ketone body influx are
not included. Notably, CBF in awake children (studies 1 and 2,
Table 4), exceeded that in awake adults, whereas CBF in N2O-
anesthetized children was lower than in awake adults and was
58% that of awake children in the same age range (studies 2, 6,
and 7, Table 4).
Inspection of Figure 2A and Supplemental Table 1 of Goyal
et al. indicates that most of the data for the 3–10-year-old
children came from two studies: Kennedy and Sokoloff (1957)
and Chugani et al. (1987). Kennedy and Sokoloff reported
whole-brain CMRO2, whereas Chugani et al. reported regional
CMRglucose (also see Table 4) so the regional or global metabolic
rates are not congruent, as required for an accurate OGI. Use
of higher cerebral cortical values for CMRglucose compared with
lower whole-brain CMRO2 will artifactually inflate themagnitude
of the CMRO2-CMRglucose mismatch. Regional variations in
CMRglucose and CMRO2 and stability of regional OGI in normal
resting adult brain (Hyder et al., 2016) support the conclusion
that errors will be incurred by combined use of global and
regional data to calculate OGI.
A caveat to the majority of studies looking at metabolic
changes during development is that often sedation or anesthesia
must be used to study young children. Of importance,
N2O stimulates brain norepinephrine release in a time- and
concentration-dependent manner, with 60% N2O increasing
norepinephrine levels by about 3-fold at 50min (Yoshida et al.,
2001, 2010), and may influence brain glucose and glycogen
metabolism and brain metabolite levels (Dienel and Cruz, 2016).
FIGURE 7 | Calculated CMRglucose and OGI as function of age in children.
Values for children from age 1-10 years were taken from Supplementary Table
1 of Goyal et al. (A) Based on the ages of the subjects in the Goyal et al.
(2014) and Chugani et al. (1987) all CMRglucose data for this age group were
assumed to be from the study of Chugani et al. who used a value of the
lumped constant (LC) of 0.42 to calculate CMRglucose in their [
18F]FDG-PET
studies (blue symbols and lines). For comparison, values at each age were
recalculated using updated values for the LC, i.e., LC = 0.65 (Wu et al., 2003)
(green) and LC = 0.80 (Wienhard, 2002; Hyder et al., 2016) (brown). To
directly compare the different CMRglucose data sets to the CMRO2 values
reported by Goyal et al. each CMRO2 was converted to glucose equivalents
(red squares) by dividing by 6 (which assumes all oxygen consumed is due to
glucose oxidation–see text), with the caveat that correction for lactate fluxes
and ketone body utilization that were not measured in these studies will alter
these values (see Table 4). (B) OGI values tabulated by Goyal et al. were
similarly corrected using LC = 0.65 or 0.8. The horizontal red line represents
the theoretical maximum of 6.0 (see text). The solid curved lines are quadratic
nonlinear regression lines calculated with GraphPad Prism 5.
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Lumped Constant and Accurate
CMRglucose Values
Calculation of OGI requires accurate and absolute values for both
rates to obtain a valid molar ratio of oxygen to glucose utilization.
However, as previously mentioned, the OGI does not have any
information about the fate of the glucose carbon consumed
in excess of oxygen. During development, there is growth and
remodeling of brain structures such as synapses, and Goyal et al.
emphasized this process as an explanation for excess glucose
consumption (Goyal et al., 2014). However, the studies used in
the meta-analysis did not measure fluxes of metabolic pathways,
and the fate of glucose is unknown and remains speculative.
The results of the present study demonstrate that lactate levels
are far, far lower than expected in developing brain, ruling out
glycolysis with lactate accumulation as a major contributor to a
fall in OGI in children. Re-calculation of CMRglucose and OGI
with updated values for the LC strongly suggests that calculated
CMRglucose is not as accurate as required, causing errors in OGI.
The OGI variability in Figure 7B is probably due, in part, to
the reported CMRO2 values that have fewer data points than
CMRglucose within this age range. These data would be most
accurate if CMRO2 and CMRglucose were sequentially determined
in the same brain regions of the same awake subjects, which
is extremely difficult, if not impossible, to carry out in young
children. In addition, determination of the net utilization of
lactate, ketone bodies, and other potential substrates in blood and
inclusion in the oxygen/substrate indicies is necessary to obtain
accurate measures of brain metabolism during development.
Another caveat is that the LC may change with age and also
depends on the model (Kuwabara et al., 1990). One component
of the LC is the ratio of the distribution space of FDG to that
for glucose. Conceivably, the distribution spaces may change
during maturation as astrocytes, neurons, and oligodendrocytes
increase transporters and metabolic enzymes, but the LC may be
relatively stable because it is a ratio. The LC has been shown to
be similar in fetal and neonatal sheep (Abrams et al., 1984) and
studies in developing brain have assumed that the LC is constant
during development (Kennedy et al., 1978, 1982; Kato et al., 1980;
Nehlig et al., 1988). Re-calculation of CMRglucose with updated
values for the LC does not invalidate the age-dependent changes
in CMRglucose reported by Chugani et al. (1987). In fact our
measured brain [Lac] values, while consistently low at all ages, do
reach a maximum at∼5 years which is the maximum CMRglucose
reported by Chugani et al. (1987).
However, and most importantly, any departure from the
true value of the LC for FDG and from the true absolute
rate of CMRglucose will invalidate the calculated OGI across
all ages, not just in young children. The analyses presented
in Figure 7 and Tables 3, 4 raise serious concerns about the
accuracy of the OGI profiles in developing brain and aging brain
reported by Goyal et al. because they did not take the use of
different LC values and utilization of supplemental substrates
into account in their meta-analysis (Goyal et al., 2014). Note
that if ketone body oxidation were measured and included in
the OGI calculations for the youngest children in Figure 7B, the
values for OGI > 6 would be reduced to close to or below 6
(see Table 4). Furthermore, Goyal et al. divided CMRO2 by 6 to
get glucose equivalents, which assumes no other substrates are
oxidized. If ketones are consumed this calculation introduces
an error into the comparison of CMRglucose and CMRO2 in
their Figure 2A because ketone bodies have different O2 -
substrate stoichiometries than glucose (legend, Table 4). While
recognizing this issue, the same calculation was used in Figure 7
in the present study so the data sets in their and our studies could
be compared. Even if the LC = 0.42 and calculated CMRglucose
are appropriate and valid in the study by Chugani et al., regional
CMRO2 was not measured in the same brain regions in the
same subjects at the same time, seriously weakening conclusions
related to the magnitude of aerobic glycolysis in children.
Moreover, as we show in this study, the commensurate lactate
levels do not match their predictions based on non-oxidative
metabolism of glucose, and thus it is premature to conclude
that 33% of the glucose consumed by 3-8-year old children
is not metabolized via the tricarboxylic acid cycle to consume
proportionate amounts of oxygen.
The brain glucose in children in the present study measured
by the LC model analysis was in the range of about 1.7–2.2mM
(results not shown),∼2 times higher than anticipated in adults at
a similar plasma glucose level based on 13C MRS measurements
and 1HMRSmeasurements at higher fields using pulse sequences
optimized for glucose detection (Gruetter et al., 1992, 1998;
de Graaf et al., 2001; Shestov et al., 2011). From four studies
in normal adults (Gruetter et al., 1992, 1998; de Graaf et al.,
2001; Shestov et al., 2011), the brain/plasma ratio for glucose
is about 0.2, and if this ratio is the same in children and we
use the mean value for brain glucose for children aged 0.5–15
years old (under N2O) of 4.89mM (Table 4), the expected brain
glucose level would be 0.98mM. Plasma glucose levels in adults
in which the LC of 0.42 (Phelps et al., 1979; Huang et al., 1980)
and 0.65 (Wu et al., 2003) were within the range 5.1–5.5mM,
with an anticipated brain concentration range of 1.0–1.1mM.
Due to limitations in the pulse sequence for measuring brain
glucose in our study, the glucose values can be deceptive in that
there can be poor accuracy but good precision (low Cramer Rao
bounds, which in our study was in the range of 10–30% for
glucose), and it is likely that the brain glucose concentrations in
children are not accurate and are overestimated. Nevertheless,
addressing this question in future studies is of importance for
obtaining accurate CMRglucose assays in children. Both brain and
plasma glucose levels will impact the value of LC, with higher
brain levels of glucose leading to somewhat lower LC values
and correspondingly-higher calculated CMRglucose, as shown for
[14C]deoxyglucose in adult animal studies (Schuier et al., 1990;
Suda et al., 1990; Dienel et al., 1991). The relationships between
the LC for FDG and brain and plasma glucose levels need to be
determined in humans across age.
To summarize, the use of supplemental fuel and metabolic
assays in different brain regions in different cohorts in which
nutritional status was not matched will cause errors in calculated
OGI. Higher metabolism of glucose via the pentose shunt
in young children with Fru-6-P recycling and release of
glucose carbon as CO2 is an important potential contributor to
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consumption of glucose in excess of oxygen. These issues must be
evaluated quantitatively before the validity of the DG method is
challenged. In this regard, regional CMRglc reported by Chugani
et al. (1987) for normal adult brain (0.2–0.27 µmol/g/min) with
LC=0.42 determined in adult brain in a separate cohort is similar
to the whole brain CMRglc (0.26µmol/g/min) reported by Hyder
et al. (2016) using FDT-PET and LC=0.8 determined in the same
subjects, and adult whole brain CMRglc reported by Madsen
et al. (1995) (0.23 µmol/g/min), calculated from measurements
of cerebral blood flow and arteriovenous differences. As discussed
above, the updated values for the LC can arise for various
technical reasons, and their use in the present study illustrates
the effects of uncertainties in the true value of the LC in
young children on the temporal profile of OGI. Changing the
value of the LC increases OGI, which would be too high when
supplemental fuels are used but not taken into account.
Limitations of the Study
The ability to measure resting lactate by 1H MRS has been
criticized based on its low levels and contamination from
brain macromolecules and lipids from the skull (arising
due to incomplete volume localization). However, based
on examination of spectra (Figure 3) the outer volume
lipid contamination was minimal. Furthermore, excellent Bo
homogeneity was achieved so that the lactate methyl group
doublet at 1.33 ppm was well-resolved from the broad
macromolecule peak at 1.3 ppm underlying lactate which would
minimize the possibility of lactate spectral intensity being
assigned to the macromolecule peak in the fitting process.
Furthermore, if all the resonance intensity at 1.3 ppm were due
to lactate, its concentration would be at most∼1mM (Figure 3),
which is still well-below what would be needed to explain the
reported OGI.
The measured values of lactate as a function of age could
potentially be influenced by changes in water and metabolite
relaxation as a result of changes in water content and the cellular
microstructural environment. Due to the challenges of studying
young children there are only a limited number of studies looking
at T2 relaxation. However, an extensive study at 1.5 T by Leppert
and coworkers found that the T2 of water in gray and white
matter rapidly decreased after birth reaching a constant value
between 10 months and 5 years (Leppert et al., 2009) which
encompasses the age range of children in our study (and at values
of T2 similar to those measured in adults). Although there are no
studies of lactate T2 changes with age it is unlikely that it would
be more sensitive than H2Owhich undergoes extensive exchange
with macromolecules and other compounds. Furthermore, the
T2 of lactate in adults at 3T is ∼200 msec (Cady et al., 1996) so
that even if it is higher in children there would be little impact on
the relative quantitation of lactate for a TE of 32 msec. Although
the macromolecule T2 is on the order of the TE (Behar et al.,
1994) there is no evidence of a change in the linewidth or relative
intensity of the 1.3 ppm macromolecule peak with age so that
the effectiveness of the LC model in separating lactate from
macromolecules would not be age dependent.
A possible confound of the present study is that the children
were studied under sevoflurane or propofol anesthesia (Jacob
et al., 2012). However a recent 1H MRS study has shown that
lactate is, in fact, elevated in mice anesthetized with volatile
halogenated anesthetics (Boretius et al., 2013), suggesting that the
awake [Lac]B values may be lower. Thus, the measured [Lac]B in
the current study, and therefore the CMRLac determined from
it, should be considered as maximal estimates. Furthermore, our
results are similar to a 3T study recently published using 1H
MRS to measure brain [Lac] in a smaller group of neonates
and children (Tomiyasu et al., 2016). Another possible confound
could be attributed to the variable anatomical voxel location for
the 1HMRS spectra which was not consistent across subjects.
We therefore acknowledge that there might have been minor
variance in the data due to region dependent differences in
metabolite levels.
Dienel and colleagues (Ball et al., 2010) have shown that
during activation up to 25% of lactate can diffuse out of regions
where it is produced by mechanisms independent of blood flow
and, therefore, lead to an underestimate of regional brain lactate
eﬄux from lactate levels alone. However, given the non-activated
(anesthetized) conditions such as the present study it is unlikely
that these mechanisms would lead to a significant underestimate
since the entire cerebral cortex of anesthetized children is at
a similar level of activity and presumably lactate production.
Future studies usingMRS imaging could further address the issue
of lactate concentration heterogeneity.
Metabolic studies in children are particularly difficult to
interpret because the duration of fasting influences plasma
ketone body levels (the longer the fast, the higher the plasma
ketone levels), brain ketone body utilization is linearly related
to plasma level, and younger children take up ketones better
than older children or adults at the same plasma level. Notably,
Kennedy and Sokoloff reported no age-dependence of CMRO2
in their awake 3–11-year-old cohort, and Settergren et al. (1980)
also reported no age correlation with CBF, CMRO2, CMRglucose,
CMRlactate, and CMRketones, in 1–15-year-old N2O-anesthetized
children (study 6, Table 4) contrasting the age-dependence of
CMRglucose in the awake children in the Chugani study (study
8). To summarize, the contributions of N2O, alerting, stress,
fear, and other factors on these metabolic differences remain to
be evaluated, underscoring the need for caution in interpreting
results of a meta-analysis in which oxygen and total substrate
utilization were not measured in the same subjects and brain
regions at the same time. Many factors complicate interpretation
of metabolic rates and OGI in children.
CONCLUSIONS
Using 1H MRS we found that [Lac] in cerebral cortex of young
children was very low, and that the maximal calculated eﬄux
of lactate cannot explain the mismatch between CMRglucose and
CMRO2 previously reported, in agreement with results of the
previousmetabolic studies in 3-15-year-old children summarized
in Table 4. Depending on plasma lactate levels it is possible that
there was a net small influx of lactate. The results of this study rule
out an increase in glycolytic rate and accumulation and release of
lactate as a primary cause of elevated non-oxidative metabolism
of glucose reported in young children. Possible explanations
for utilization of the “missing” glucose in excess of oxygen
are carbon loss as CO2 via the pentose phosphate pathway,
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use of carbon for nucleotide synthesis, protein synthesis, lipid
synthesis, and glycogen turnover with lactate eﬄux. However,
the most significant sources of disagreement are likely the (i)
validity of assumptions made in PET studies regarding the true
value of the LC, which we believe requires that the present
understanding of how OGI and CMRglucose change with age be
reexamined, (ii) use of fuel in addition to glucose, and (iii) assays
of CMRglucose and CMRO2 in different brain regions of different
subjects. To summarize, enhanced non-oxidative metabolism of
glucose during brain maturation is a complex phenomenon to
which many metabolic pathways, fuel sources, and technical
issues have a strong influence. Brain developmental progress
certainly plays a role in metabolic changes with age, but their
quantitative contributions remain to be established. In spite of
these interpretive limitations, 1H MRS provides a potentially
valuable new biomarker for assessing non-oxidative metabolism
of glucose in infants and children and studying its relationship to
brain development in health and disease.
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